Biomerica Statistics
Total Valuation
Biomerica has a market cap or net worth of $4.69 million. The enterprise value is $2.58 million.
Important Dates
The next estimated earnings date is Tuesday, January 14, 2025, before market open.
| Earnings Date | Jan 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomerica has 16.82 million shares outstanding. The number of shares has increased by 11.52% in one year.
| Current Share Class | 16.82M |
| Shares Outstanding | 16.82M |
| Shares Change (YoY) | +11.52% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.22% |
| Owned by Institutions (%) | 11.40% |
| Float | 15.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.85 |
| Forward PS | n/a |
| PB Ratio | 0.88 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.00, with a Debt / Equity ratio of 0.13.
| Current Ratio | 3.00 |
| Quick Ratio | 2.03 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -76.48% and return on invested capital (ROIC) is -45.59%.
| Return on Equity (ROE) | -76.48% |
| Return on Assets (ROA) | -38.54% |
| Return on Capital (ROIC) | -45.59% |
| Revenue Per Employee | $86,078 |
| Profits Per Employee | -$96,281 |
| Employee Count | 64 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.63 |
Taxes
In the past 12 months, Biomerica has paid $23,000 in taxes.
| Income Tax | 23,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.50% in the last 52 weeks. The beta is -1.11, so Biomerica's price volatility has been lower than the market average.
| Beta (5Y) | -1.11 |
| 52-Week Price Change | -80.50% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | 0.49 |
| Relative Strength Index (RSI) | 41.07 |
| Average Volume (20 Days) | 2,350,799 |
Short Selling Information
The latest short interest is 1.43 million, so 8.48% of the outstanding shares have been sold short.
| Short Interest | 1.43M |
| Short Previous Month | 371,646 |
| Short % of Shares Out | 8.48% |
| Short % of Float | 9.13% |
| Short Ratio (days to cover) | 2.28 |
Income Statement
In the last 12 months, Biomerica had revenue of $5.51 million and -$6.16 million in losses. Loss per share was -$0.37.
| Revenue | 5.51M |
| Gross Profit | 488,000 |
| Operating Income | -6.50M |
| Pretax Income | -6.30M |
| Net Income | -6.16M |
| EBITDA | -6.42M |
| EBIT | -6.50M |
| Loss Per Share | -$0.37 |
Full Income StatementBalance Sheet
The company has $2.82 million in cash and $707,000 in debt, giving a net cash position of $2.11 million or $0.13 per share.
| Cash & Cash Equivalents | 2.82M |
| Total Debt | 707,000 |
| Net Cash | 2.11M |
| Net Cash Per Share | $0.13 |
| Equity (Book Value) | 5.35M |
| Book Value Per Share | 0.32 |
| Working Capital | 4.29M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.03 million and capital expenditures -$30,000, giving a free cash flow of -$5.06 million.
| Operating Cash Flow | -5.03M |
| Capital Expenditures | -30,000 |
| Free Cash Flow | -5.06M |
| FCF Per Share | -$0.30 |
Full Cash Flow StatementMargins
Gross margin is 8.86%, with operating and profit margins of -118.04% and -111.85%.
| Gross Margin | 8.86% |
| Operating Margin | -118.04% |
| Pretax Margin | -111.44% |
| Profit Margin | -111.85% |
| EBITDA Margin | -116.57% |
| EBIT Margin | -118.04% |
| FCF Margin | n/a |